Sesartemin



Compound IDCDAMM01445
Common nameSesartemin
IUPAC name4-methoxy-6-[6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodioxole
Molecular formulaC23H26O8

Experimental data

Retention time3.74
Adduct[M+K]+
Actual mz469.129
Theoretical mz469.126
Error5.42
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7293

Identifiers and class information

Inchi keyDHWUVPPRBIJJKS-UHFFFAOYNA-N
SmilesO(C=1C=C(C=C(OC)C1OC)C2OCC3C(OCC23)C4=CC(OC)=C5OCOC5=C4)C
SuperclassLignans, neolignans and related compounds
ClassFuranoid lignans

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)430.454
Computed dipole moment(dipole)4.879
Total solvent accessible surface area (SASA)604.713
Hydrophobic component of SASA (FOSA)510.96
Hydrophilic component of SASA (FISA)0
Pie component of the SASA (PISA)93.753
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1188.24
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)7.9
Free energy of solvation of dipole (dip^2/V)0.0200316
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.897195
Predicted polarizability in cubic angstroms (QPpolrz)39.726
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.021
Predicted octanol/gas partition coefficient (QPlogPoct)17.016
Predicted water/gas partition coefficient (QPlogPw)8.711
Predicted octanol/water partition coefficient (QPlogPo/w)1.528
Predicted aqueous solubility (QPlogS)-3.399
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.399
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.643
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)9906.04
Predicted brain/blood partition coefficient (QPlogBB)-2.397
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5899.29
Predicted skin permeability, log Kp (QPlogKp)-0.805
PM3 calculated ionization potential (IP(ev))8.931
PM3 calculated electron affinity (EA(eV))-0.044
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)-0.216
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)67.124
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q07820MCL1Induced myeloid leukemia cell differentiation protein Mcl-1T14912SwissTargetPrediction
P53779MAPK10c-Jun N-terminal kinase 3T85421SwissTargetPrediction
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SwissTargetPrediction
O00206TLR4Toll-like receptor 4 (by homology)T81443SEA
P08183ABCB1P-glycoprotein 1T25258SEA
P25105PTAFRPlatelet activating factor receptorT87023SwissTargetPrediction and SEA
P25101EDNRAEndothelin receptor ET-AT23499SEA
P24530EDNRBEndothelin receptor ET-BT92828SEA
P00746CFDComplement factor DT66383SwissTargetPrediction
P51843NR0B1Orphan nuclear receptor DAX-1T23191SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
Q9P0J0NDUFA13Mitochondrial complex IT82391SEA
Q9Y6M9NDUFB9HUMAN NADH:ubiquinone oxidoreductase subunit B9T01465SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
P03897MT-ND3NADH dehydrogenaseT77195SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T14912DI0012Acute myeloid leukaemia[ICD-11: 2A60]Q07820MCL1
T14912DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]Q07820MCL1
T14912DI0250Mature B-cell lymphoma[ICD-11: 2A85]Q07820MCL1
T14912DI0252Melanoma[ICD-11: 2C30]Q07820MCL1
T14912DI0274Multiple myeloma[ICD-11: 2A83]Q07820MCL1
T14912DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q07820MCL1
T85421DI0125Dissociative neurological symptom disorder[ICD-11: 6B60]P53779MAPK10
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T81443DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]O00206TLR4
T81443DI0346Prostate cancer[ICD-11: 2C82]O00206TLR4
T81443DI0375Sepsis[ICD-11: 1G40-1G41]O00206TLR4
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T87023DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P25105PTAFR
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T92828DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P24530EDNRB
T92828DI0356Pulmonary hypertension[ICD-11: BB01]P24530EDNRB
T66383DI0170Haemolytic anemia[ICD-11: 3A20-3A2Z]P00746CFD
T66383DI0365Retinopathy[ICD-11: 9B71]P00746CFD
T82391DI0069Cardiomyopathy[ICD-11: BC43]Q9P0J0NDUFA13
T77195DI0331Parkinsonism[ICD-11: 8A00]P03897MT-ND3

Copyright © 2025